Bulletin of the World Health Organization

Schizophrenia treatment in the developing world: an interregional and multinational cost-effectiveness analysis

Dan Chisholm, Oye Gureje, Sandra Saldivia, Marcelo Villalón Calderón, Rajitha Wickremasinghe, Nalaka Mendis, Jose-Luis Ayuso-Mateos, Shekhar Saxena

Volume 86, Number 7, July 2008, 542-551

Table 1. Epidemiological ratesa for schizophrenia in three WHO subregionsb

WHO region Age(years) Males
Females
Incidence Prevalence Remission Case fatality Incidence Prevalence Remission Case fatality
Africa 15–29 0.48 3.15 26.9 2.7 0.39 2.38 26.9 2.9
subregion D 30–44 0.22 6.08 29.2 4.7 0.49 7.52 29.3 4.3
45–59 0.08 4.71 29.1 7.3 0.10 6.39 29.1 5.7
Nigeria 60–69 0.05 3.78 29.2 15.6 0.05 5.10 29.8 15.3
70–79 0.12 2.82 29.0 32.9 0.01 3.17 29.3 31.9
80+ 0.21 2.42 29.0 70.4 0.12 1.88 29.0 68.9

Americas 15–29 0.49 4.00 29.3 1.0 0.59 4.78 29.4 0.3
subregion B 30–44 0.19 5.99 29.1 1.7 0.11 6.28 29.1 0.7
45–59 0.20 6.00 29.0 4.0 0.19 6.00 29.0 2.3
Chile 60–69 0.24 6.00 29.0 10.1 0.21 6.00 29.0 6.5
70–79 0.30 6.00 29.0 21.5 0.26 6.00 29.0 14.6
80+ 0.47 6.00 29.0 49.1 0.41 6.00 29.0 38.5

South-East Asia 15–29 0.59 5.26 29.4 1.2 0.56 4.32 29.5 0.7
subregion B 30–44 0.17 7.33 29.1 1.8 0.28 7.75 29.1 1.1
45–59 0.16 6.40 29.0 4.0 0.19 7.17 29.0 3.1
Sri Lanka 60–69 0.06 5.45 29.1 9.6 0.06 6.16 29.0 8.1
70–79 0.12 4.29 29.0 20.8 0.11 4.68 29.0 19.4
80+ 0.17 3.25 29.0 47.3 0.16 3.42 29.1 47.3

a Rate per 1000 population.b DisMod II software (© WHO) was used to produce these data.Source: WHO Global Burden of Disease study22

[an error occurred while processing this directive]